Patra NeurosurgicalPatient education

Procedure

Vagus nerve stimulation (VNS)

An implanted device in the chest sends mild electrical pulses to the vagus nerve in the neck. It is used with medicine to reduce how often seizures happen.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

What it does

The vagus nerve runs from the brain down through the neck. In VNS, a small generator is placed under the skin of the upper left chest. A thin wire runs from it to the vagus nerve in the neck. The device sends regular, mild electrical signals to the brain through this nerve. [1] [2] Doctors do not fully understand how it works. [1]

VNS is an add-on to seizure medicine. It does not cure epilepsy. [1]

When it is considered

FDA approval. The US Food and Drug Administration (FDA) approves VNS as an add-on treatment to reduce how often seizures happen. The approval covers people 4 years and older with partial-onset (focal) seizures that have not responded to seizure medicines. The age range was expanded from over 12 to 4 and older in 2017. [3]

VNS may be considered when: [1]

Use outside the approved label. Doctors sometimes use VNS for generalized epilepsy or Lennox-Gastaut syndrome (a severe childhood-onset epilepsy). This is off-label use. A guideline found low-level evidence that VNS may help in these groups. [4]

What matters most in the decision

VNS usually reduces seizures rather than stopping them. Complete seizure freedom is rare. About a quarter of people get no benefit. [5] The procedure does not involve opening the skull. [6]

Preparation and what happens

The surgeon makes two cuts, one in the neck and one below the collarbone. It is usually an outpatient procedure. [7]

Expected benefits

Studies of VNS mostly measure responder rate. This is the share of people whose seizures drop by half or more. It is different from seizure freedom.

Programming

After the implant, a clinician adjusts the settings at clinic visits using a programmer. [7] [1] Settings can be changed to ease side effects. Some newer models can give extra stimulation when they detect a sudden rise in heart rate. [1]

The magnet

You receive a magnet. [1]

Ask your team how and when to use each.

Risks and complications

Voice and breathing effects during stimulation. Hoarseness or voice change is the most common side effect. It happened in about 50 out of 100 people in the FDA review. [3] Cough, shortness of breath, pain, tingling, nausea, and headache can also occur. Hoarseness and shortness of breath were more common with higher settings. [8] Significant breathing problems such as sleep apnea may make VNS less suitable. [1]

Infection. Children have a higher risk of infection at the implant site than adults. [4]

Battery replacement and repeat surgery. The battery wears out over time. In a study of 644 people, about 46 out of 100 needed at least one more operation over the years. About 27 out of 100 had surgery to replace a worn-out battery. Others needed surgery for poor results or wire problems. About 2 out of 100 had an infection. [9]

Alternatives

Recovery and follow-up

Expect regular visits to adjust settings. Benefit often builds over months to years. [5] [4] Keep taking seizure medicine. Any change should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.

Questions to ask

  1. Is my seizure type covered by the FDA approval, or would this be off-label?
  2. What change in my seizures would count as success?
  3. How long will my battery likely last?
  4. How should I use the magnet, and who else should learn?
  5. Can I have an MRI with this device?

Sources

  1. Vagus Nerve Stimulation (VNS) Therapy. Epilepsy Foundation. Published July 17, 2026. Open source
  2. Epilepsy and Seizures. National Institute of Neurological Disorders and Stroke. Published March 13, 2026. Open source
  3. US Food and Drug Administration. Summary of Safety and Effectiveness Data: VNS Therapy System, PMA P970003/S207 (indication expanded to patients 4 years of age and older). Approved June 23, 2017. Published June 23, 2017. Open source
  4. Morris GL 3rd, Gloss D, Buchhalter J, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453-1459. Published August 28, 2013. Open source
  5. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248-1255. Published August 12, 2011. Open source
  6. Tanoue Y, Izumi M, Ahn SS, et al. Safety and adverse event profiles in neuromodulation therapies for drug-resistant epilepsy. Neurotherapeutics. 2026;23(4):e01042. Published August 18, 2026. Open source
  7. Epilepsy. American Association of Neurological Surgeons. Published April 15, 2024. Open source
  8. Panebianco M, Rigby A, Marson AG. Vagus nerve stimulation for focal seizures. Cochrane Database Syst Rev. 2022;7(7):CD002896. Published July 14, 2022. Open source
  9. Couch JD, Gilman AM, Doyle WK. Long-term expectations of vagus nerve stimulation: a look at battery replacement and revision surgery. Neurosurgery. 2016;78(1):42-46. Published January 1, 2016. Open source
  10. Rolston JD, Englot DJ, Wang DD, Garcia PA, Chang EF. Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: a systematic review. Epilepsy Behav. 2015;51:13-17. Published August 3, 2015. Open source